Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1998;98:1043-1044

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aguilaniu, B.
Right arrow Articles by Agostoni, P.G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aguilaniu, B.
Right arrow Articles by Agostoni, P.G.

(Circulation. 1998;98:1043-1044.)
© 1998 American Heart Association, Inc.


Correspondence

Lung Function and Exercise Gas Exchange in Chronic Heart Failure

Bernard Aguilaniu, MD; ; Eric Page, MD

Unité de diagnostic cardio-pulmonaire à l'exercice, Laboratoire de physiopathologie de l'exercice, Grenoble, France

François Peronnet, PhD

Unité de formation et de recherche, activité physique et sparkine Université Joseph Fourier, Grenoble, France, Université de Montréal, Montréal, Canada

Hélène Perrault, PhD

Unité de formation et de recherche, activité physique et sparkine, Université Joseph Fourier, Grenoble, France, McGill University, Montréal, Canada

To the Editor:

This letter follows the report from a multicenter study of exercise ventilatory and gas exchange responses in 130 patients with heart failure (HF).1 Average exercise PaO2 and PAO2 were observed to be normal in spite of a relatively high VD/VT, which was compensated for by a marked hyperventilation (E/O2 close to 40 even at comparatively low workloads). The authors thus suggest that patients with HF present a condition of reduced perfusion in a well-ventilated lung with no disturbance in gas exchange. The mean P(A-a)O2 was indeed found to be normal at {approx}20 mm Hg. However, PaO2, P(A-a)O2, and, to a lesser extent, PAO2 were widely dispersed around average values. In a large number of patients, supranormal values, seldom observed in clinical practice, were observed for PaO2 (>110 mm Hg in {approx}30 patients), PAO2 (>130 mm Hg in {approx}15 patients), and P(A-a)O2 (<10 mm Hg in {approx}30 patients). These values at the upper range of the distributions correctly fit the description of a "reduced perfusion in a well-ventilated lung." In contrast, at the lower range of the distribution, {approx}30 patients exhibited P(A-a)O2 values >30 mm Hg, and this was independent of the achieved peak O2. It should be remembered that in 77 subjects with normal lung function and gas exchange, Hansen et al2 observed exercise P(A-a)O2 >35 mm Hg in only 3. We thus believe that the simple and attractive "high VA/Q" model due to a high VD/VT proposed to explain the exaggerated ventilatory response in patients with HF only fits a limited number of these patients, namely, those with normal or supranormal P(A-a)O2 values. However, the large prevalence of a wide exercise P(A-a)O2 in these patients suggests that additional factors can contribute to the marked hyperventilation observed, such as ventilation-perfusion mismatch due to poor alveolar ventilation and/or diffusion limitation. These and other possible disturbances in lung function and gas exchange in patients with HF should not be overlooked in clinical practice.

References

  1. Wasserman K, Zhang Y-Y, Gitt A, Belardinelli R, Koike A, Lubarsky L, Agostoni PG. Lung function and exercise gas exchange in chronic heart failure. Circulation. 1997;96:2221–2227.[Abstract/Free Full Text]
  2. Hansen JE, Sue DY, Wasserman K. Predicted values for clinical exercise testing. Am Rev Respir Dis. 1984;129(suppl):S49–S55.

Response

K. Wasserman, MD, PhD; Y-Y. Zhang, MD; ; L. Lubarsky, MD

Harbor–UCLA Medical Center, UCLA School of Medicine, Torrance, Calif

A. Gitt, MD

Herzzentrum Ludwigshafen Department of Cardiology and Pneumonology, Ludwigshafen, Germany

R. Belardinelli, MD

Ospedale Cardiologico G.M. Lancisi Ancona, Italy

A Koike, MD

2nd Department of Internal Medicine Tokyo Medical and Dental University, Tokyo, Japan

P.G. Agostoni, MD

Istituto di Cardiologia dell'Universita degli Studi Centro di Studio per le Richerche Cardiovascolari del Consiglio Nazionale delle Richerche, Milan, Italy

In response to the letter of Aguilaniu and colleagues, we must point out that their letter incorrectly describes our findings.1 They state that we "suggest that patients with HF" have "no disturbance in gas exchange." We did find a disturbance in gas exchange in our patients with chronic HF, the nature of which was the primary message of our article. We found that the dead space/tidal volume ratio (VD/VT) and arterial-end tidal PCO2 difference [P(a-ET)CO2] increased systematically as peak exercise performance decreased. These findings indicate that high ventilation-perfusion (A/) ratio lung units developed as exercise tolerance worsened, findings expected with regional reduction in pulmonary blood flow relative to ventilation. In contrast, the average arterial PO2 (PaO2) and alveolar-arterial PO2 difference [P(A-a)O2] values remained normal at peak exercise and were uninfluenced by the severity of the exercise. These observations suggest that there is no systematic development of low A/ lung units as exercise tolerance worsens.

The letter of Aguilaniu et al has as its main concern the values of PaO2 and P(A-a)O2 in our HF patients. They used the study of Hansen et al2 as the reference for normal values (adult men with average age of 54 years). These values in our HF population have a greater dispersion than reported by Hansen et al2 (PaO2=98.1±15.3 versus 100.6±9.9 for the HF and normal populations, respectively, and P(A-a)O2=20.5±13.7 versus 19.0±8.8 for the HF and normal populations, respectively, mean±SD. These values are not significantly different. Nine of our 83 patients had a PaO2 value ranging from 61 to 79 at peak exercise, values that we regard to be abnormal. However, these low values were not systematically related to the extent of exercise limitation. Aguilaniu et al state that a PaO2 of >110 at maximal exercise is seldom seen in clinical practice at peak exercise. I am not sure of the altitude of the laboratory at which Dr Aguilaniu et al work (critically important), but at sea level, these values, while not usual, are not uncommon at peak exercise. Given the data of Hansen et al,2 10 (13.5%) of 74 normal subjects had a PaO2 value >110 at peak exercise compared with 17 (20.5%) of 83 in our HF population. The high values at peak exercise could be accounted for by a combination of hyperventilation and high respiratory exchange ratio (RER). Thus, the alveolar PO2 will become 130 when PaCO2=27 and RER=1.5 (only 3 of our 83 patients had PAO2 values in the range of 130).

The increased dispersion in our HF population might have been due to chronic changes resulting from repeated episodes of pulmonary edema or the ravages of chronic cigarette smoking. We did not prescreen our HF patients for subtle pulmonary disease, as was done by Hansen et al.2 We also cannot exclude the possibility that random technical errors might have occurred in this multicenter study to account for the increased dispersion of our data compared with that reported by Hansen et al.2

The major finding described in our report is that patients with chronic HF have unique lung pathophysiology. They develop high A/ ratio lung units as exercise capacity worsens, without development of low A/ ratio lung units. This impairment-related abnormality in lung function, along with the increased VCO2 relative to O2 that our study describes, may account for the high frequency of dyspnea reported by HF patients.

References

  1. Wasserman K, Zhang Y-Y, Gitt A, Belardinelli R, Koike A, Lubarsky L, Agostoni PG. Lung function and exercise gas exchange in chronic heart failure. Circulation. 1997;96:2221–2227.
  2. Hansen JE, Sue DY, Wasserman K. Predicted values for clinical exercise testing. Am Rev Respir Dis. 1984;129(suppl)S49–S55.




This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aguilaniu, B.
Right arrow Articles by Agostoni, P.G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aguilaniu, B.
Right arrow Articles by Agostoni, P.G.